Skip to main content

Table 2 Stratified analyses for the association between TLS and OS of digestive system cancers by key factors

From: Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis

 

Subgroup

Number of studies

Pooled results HR(95%CI)

Heterogeneity test

I2(%)

p

Sample size

 ≥ 200

10

1.34 (1.31–1.61)

25.51

0.21

 < 200

8

2.52 (1.99–3.20)

22.85

0.25

Metastasis

No

8

1.82 (1.34–2.48)

68.981

 < 0.01

Yes

8

1.86 (1.49–2.33)

48.98

0.06

NA

2

1.44 (1.26–1.65)

0

0.44

Cut-off criteria

Presence vs. Absence

8

1.69 (1.36–2.10)

48.15

0.05

High vs. Low

10

1.85 (1.45–2.35)

64.64

 < 0.01

Types

ESCC

3

1.76 (0.86–3.61)

80.21

 < 0.01

GC

8

1.54 (1.33–1.79)

28.80

0.20

CRC

1

2.42 (1.24–4.74)

NA

NA

HCC

3

2.05 (1.08–3.88)

70.89

0.03

PC

3

3.37 (1.09–10.37)

71.76

0.03

  1. Abbreviations: ESCC esophageal squamous cell carcinoma, CRC colorectal cancer, GC gastric cancer, HCC hepatocellular carcinoma, PC pancreatic cancer, OS overall survival, RFS relapse-free survival, DFS disease-free survival, TLS tertiary lymphoid structure, NA not available